Skip to main content
Clinical Trials/NCT02440542
NCT02440542
Withdrawn
Not Applicable

Popliteal Nerve Block for Postoperative Pain Control in Patients Undergoing Ankle and Hindfoot Reconstruction About the Talus

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain, Postoperative
Sponsor
University of Tennessee
Primary Endpoint
Pain rating
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to evaluate outcomes of popliteal nerve blocks for postoperative pain control in patients undergoing ankle and hindfoot reconstruction surgeries. The following outcomes will be analyzed: length of hospital stay, level of pain control, pain medication use, complications, and patient satisfaction.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
May 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patients ≥ 18 years old
  • Patients undergoing ankle, subtalar, pantalar, triple, or tibiotalocalcaneal arthrodesis (CPT codes 27870, 28715, 28725, or 28740)
  • Patients undergoing total ankle arthroplasty (CPT code 27702)
  • Patients with a preoperative surgical plan to receive a popliteal nerve block during the postoperative period
  • Patients whom can be reasonably expected to understand and comply with patient-reported postoperative data collection and surveys

Exclusion Criteria

  • Patients undergoing an ankle or hindfoot reconstruction procedure whom are medically ineligible to receive a safe popliteal nerve block (i.e. patients with neuropathy)
  • Patients with documented substance abuse (i.e. history of narcotic abuse could confound pain outcomes)

Outcomes

Primary Outcomes

Pain rating

Time Frame: Postoperative- through 12 weeks

Measured by VAS

Secondary Outcomes

  • Narcotic intake(Postoperative- through 12 weeks)
  • Hospital length of stay(Postoperative- through day of hospital discharge (discharge same day of surgery to approximately 3 days postop))
  • Patient satisfaction(Postoperative- through first surgical follow-up (up to 3 weeks))

Similar Trials